Europe Infusion Pumps Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Europe Infusion Pumps Market Size

• The Europe Infusion Pumps market size was valued at USD 1.67 billion in 2025 and is expected to reach USD 2.67 billion by 2033, at a CAGR of 6.05% during the forecast period
• The market growth is largely fueled by the increasing adoption of advanced drug delivery systems and technological advancements in smart and programmable infusion devices, leading to improved accuracy, patient safety, and efficiency across hospitals, ambulatory centers, and homecare settings
• Furthermore, rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, along with growing demand for continuous and controlled medication administration, is establishing infusion pumps as a critical component of modern healthcare delivery. These converging factors are accelerating the uptake of Infusion Pumps solutions, thereby significantly boosting the industry's growth

Europe Infusion Pumps Market Analysis

• Infusion pumps, offering controlled and precise delivery of medications and fluids, are increasingly vital components of modern healthcare systems across hospitals, ambulatory surgical centers, and homecare settings due to their enhanced dosing accuracy, safety features, and integration with digital monitoring systems
• The escalating demand for infusion pumps is primarily fueled by the rising prevalence of chronic diseases such as diabetes and cancer, growing need for continuous drug administration, increasing hospital admissions, and a strong shift toward home-based care solutions
• The U.K. dominated the Infusion Pumps market with the largest revenue share of 29.7% in 2025, characterized by advanced healthcare infrastructure, high adoption of smart infusion technologies, strong NHS procurement systems, and increasing implementation of safety-enabled and programmable infusion systems across hospitals and specialty care centers
• Germany is expected to be the fastest-growing country in the Infusion Pumps market during the forecast period, expanding at a CAGR of 8.6% from 2026 to 2033, due to increasing investments in hospital modernization, rising geriatric population, growing burden of chronic diseases, and rapid adoption of advanced infusion management technologies
• The devices segment dominated the largest market revenue share of 58.4% in 2025, driven by increasing adoption of volumetric, syringe, and ambulatory infusion pumps across hospitals and home care settings

Report Scope and Infusion Pumps Market Segmentation     

Europe Infusion Pumps Market Trends

Advancements in Smart and Connected Infusion Pump Technologies

• A significant and accelerating trend in the infusion pumps market is the increasing adoption of advanced programmable and digitally integrated infusion systems designed to enhance medication accuracy, patient safety, and clinical workflow efficiency. Hospitals are transitioning from traditional infusion systems to smart pumps equipped with drug libraries, dose error reduction systems (DERS), and wireless connectivity for centralized monitoring
  • For instance, leading European hospitals have implemented smart infusion pump systems with integrated dose-error reduction software to minimize medication errors in intensive care units and oncology departments, significantly improving patient safety outcomes
• Modern infusion pumps now incorporate advanced features such as real-time monitoring, automated alerts for dosage deviations, and interoperability with hospital electronic medical record (EMR) systems, enabling seamless clinical documentation and improved treatment accuracy
• The integration of infusion systems with hospital IT infrastructure is streamlining medication administration processes, reducing manual documentation errors, and supporting compliance with strict European patient safety regulations
• This shift toward safer, digitally connected infusion technologies is reshaping hospital procurement strategies, prompting manufacturers to develop compact, user-friendly, and highly accurate infusion systems tailored for critical care, ambulatory, and home healthcare settings
• The demand for advanced infusion pumps is steadily rising across hospitals, ambulatory surgical centers, and home care environments, as healthcare providers prioritize patient safety, workflow optimization, and regulatory compliance

Europe Infusion Pumps Market Dynamics

Driver

Rising Prevalence of Chronic Diseases and Increasing Surgical Procedures

• The growing burden of chronic diseases such as diabetes, cancer, and cardiovascular disorders across Europe is a major driver accelerating demand for infusion pumps, as these conditions often require continuous and precise drug administration
  • For instance, the increasing number of chemotherapy treatments administered in oncology centers across Germany and France has significantly boosted the demand for volumetric and syringe infusion pumps to ensure accurate drug delivery
• The rising number of surgical procedures and expanding intensive care admissions are further contributing to higher utilization of infusion systems for anesthesia delivery, pain management, and critical care treatments
• In addition, the expanding elderly population across Europe, which is more susceptible to chronic illnesses, is increasing the need for long-term infusion therapies in both hospital and home-care settings
• Government initiatives promoting patient safety standards and medication error reduction are also encouraging healthcare facilities to replace conventional infusion devices with advanced programmable systems

Restraint/Challenge

High Equipment Costs and Risk of Medication Errors

• Despite technological advancements, the high initial cost of advanced infusion pump systems and associated maintenance expenses can limit adoption, particularly in smaller healthcare facilities and budget-constrained regions
  • For instance, the installation of fully integrated smart infusion pump systems in mid-sized European hospitals often requires substantial capital investment, including software upgrades and staff training, which may delay procurement decisions
• Operational challenges such as programming complexity, risk of dosage errors due to improper configuration, and the need for continuous staff training remain significant concerns for healthcare providers
• Furthermore, stringent regulatory requirements and compliance standards in Europe increase the time and cost associated with product approvals and market entry for manufacturers
• Addressing these challenges through cost-effective system development, simplified user interfaces, enhanced training programs, and supportive reimbursement policies will be essential for sustained growth in the Europe Infusion Pumps market

Europe Infusion Pumps Market Scope

The market is segmented on the basis of product type, application, and end use.

• By Product Type

On the basis of product type, the Infusion Pumps market is segmented into accessories and consumables, and devices. The devices segment dominated the largest market revenue share of 58.4% in 2025, driven by increasing adoption of volumetric, syringe, and ambulatory infusion pumps across hospitals and home care settings. Rising prevalence of chronic diseases such as cancer and diabetes significantly fuels demand for infusion systems. Technological advancements including smart pumps with dose error reduction systems enhance patient safety. Growing hospital admissions and surgical procedures further support segment dominance. Integration with electronic health records improves workflow efficiency. Favorable reimbursement policies in developed regions strengthen procurement. Increasing geriatric population requiring long-term drug administration sustains usage. Expansion of critical care units and oncology centers accelerates deployment. Continuous innovation in portable and battery-operated pumps enhances flexibility. Strong regulatory approvals and safety compliance reinforce adoption. Hospital investments in advanced infusion infrastructure further contribute to revenue growth.

The accessories and consumables segment is expected to witness the fastest CAGR of 13.9% from 2026 to 2033, fueled by recurring demand for IV sets, tubing, catheters, and syringes. Rising number of infusion procedures globally accelerates consumption rates. Increasing shift toward home-based therapy boosts disposable product usage. Infection control protocols encourage frequent replacement of consumables. Technological advancements in anti-microbial and safety-engineered consumables enhance adoption. Growing outpatient and ambulatory procedures strengthen segment growth. Expansion of chronic disease management programs increases utilization. Cost-effectiveness and continuous replenishment cycles ensure stable revenue streams. Government initiatives supporting safe infusion practices further drive demand. Increasing awareness about cross-contamination prevention promotes higher usage rates. Expanding healthcare access in emerging economies accelerates market penetration.

• By Application

On the basis of application, the Infusion Pumps market is segmented into chemotherapy/oncology, diabetes management, gastroenterology, pain management/analgesia, pediatrics/neonatology, hematology, and other applications. The chemotherapy/oncology segment dominated the largest market revenue share of 36.7% in 2025, driven by the increasing global cancer burden and growing demand for precise drug delivery systems. Infusion pumps enable controlled administration of chemotherapeutic agents, reducing toxicity risks. Rising adoption of ambulatory infusion pumps in outpatient oncology centers supports growth. Favorable reimbursement frameworks for cancer treatment enhance procurement. Expanding oncology infrastructure and specialty hospitals further boost demand. Technological improvements in programmable pumps enhance dosage accuracy. Increasing prevalence of targeted therapies requiring continuous infusion sustains market expansion. Growth in clinical trials and combination therapy protocols supports device utilization. Higher survival rates and longer treatment cycles increase usage frequency.

The diabetes management segment is projected to witness the fastest CAGR of 14.6% from 2026 to 2033, fueled by the growing prevalence of type 1 and type 2 diabetes worldwide. Rising adoption of insulin infusion pumps and wearable patch pumps accelerates market growth. Integration with continuous glucose monitoring systems enhances glycemic control. Increasing awareness about advanced diabetes care improves adoption rates. Government screening initiatives support early diagnosis and management. Technological advancements such as closed-loop insulin delivery systems strengthen demand. Growing pediatric diabetic population further drives utilization. Expansion of home-based care solutions boosts uptake. Favorable reimbursement in developed markets accelerates penetration. Continuous innovation in compact and user-friendly devices sustains high CAGR growth.

• By End Use

On the basis of end use, the Infusion Pumps market is segmented into hospitals, home care settings, ambulatory care settings, and academic and research institutes. The hospitals segment dominated the largest market revenue share of 47.9% in 2025, due to high patient volumes and availability of advanced infusion infrastructure. Hospitals extensively use infusion pumps in ICUs, oncology departments, and surgical units. Increasing inpatient admissions support consistent demand. Availability of trained healthcare professionals ensures optimal device utilization. Strong reimbursement policies promote capital equipment acquisition. Expansion of tertiary care hospitals enhances market presence. Integration with centralized monitoring systems improves medication safety. Rising prevalence of chronic and acute diseases further drives hospital usage. Investments in smart infusion pump technologies strengthen segment dominance. High procedural volumes justify multiple device installations.

The home care settings segment is expected to witness the fastest CAGR of 15.2% from 2026 to 2033, driven by increasing preference for home-based chronic disease management. Portable and wearable infusion pumps enhance patient mobility and convenience. Rising healthcare costs encourage shift toward cost-effective home therapies. Technological advancements in compact and battery-operated pumps support adoption. Growing geriatric population fuels demand for long-term infusion therapy. Telehealth integration enables remote monitoring by clinicians. Favorable insurance coverage enhances affordability. Increasing awareness regarding self-administration improves acceptance. Expansion of outpatient chemotherapy and insulin therapy programs accelerates uptake. Continuous innovation in user-friendly designs sustains strong growth momentum.

Europe Infusion Pumps Market Regional Analysis

• The Europe Infusion Pumps market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by the rising prevalence of chronic diseases, increasing surgical procedures, and growing demand for accurate and controlled drug delivery systems across hospitals and home care settings
• The growing geriatric population across Europe, particularly patients requiring long-term intravenous therapies such as chemotherapy, parenteral nutrition, and pain management, is significantly contributing to market growth. In addition, strong regulatory frameworks emphasizing patient safety and medication error reduction are accelerating the adoption of programmable and safety-enabled infusion systems. Technological advancements such as smart pumps with dose error reduction systems (DERS), integration with hospital information systems, and wireless connectivity are further strengthening market expansion
• The region is witnessing increased deployment of infusion pumps across hospitals, ambulatory surgical centers, specialty clinics, and home healthcare environments, supported by well-established healthcare infrastructure and favorable reimbursement systems

U.K. Infusion Pumps Market Insight

The U.K. Infusion Pumps market dominated the Europe market with the largest revenue share of 29.7% in 2025 and is anticipated to grow at a noteworthy CAGR during the forecast period. This dominance is characterized by the country’s advanced healthcare infrastructure, strong centralized procurement framework under the National Health Service (NHS), and high adoption of technologically advanced infusion systems. Hospitals and specialty care centers across the U.K. are increasingly implementing programmable infusion pumps equipped with safety software to minimize medication errors and enhance patient outcomes. The growing incidence of cancer, diabetes, and cardiovascular diseases is significantly driving the demand for continuous and controlled drug administration devices. Furthermore, increasing emphasis on patient safety initiatives, digital healthcare transformation, and integration of infusion pumps with electronic health records (EHR) systems is strengthening market growth. The expansion of home-based healthcare services and outpatient infusion therapies is also contributing to sustained demand across the country.

Germany Infusion Pumps Market Insight

The Germany Infusion Pumps market is expected to be the fastest-growing country in Europe during the forecast period, expanding at a CAGR of 8.6% from 2026 to 2033. Market growth is fueled by increasing investments in hospital modernization programs, rising healthcare expenditure, and strong government focus on improving medical technology infrastructure. Germany’s rapidly aging population and growing burden of chronic diseases such as cancer, autoimmune disorders, and metabolic conditions are significantly increasing the demand for advanced infusion therapies. In addition, healthcare providers are adopting innovative infusion management technologies that enhance dosing accuracy, improve workflow efficiency, and reduce adverse drug events. The expansion of ambulatory care facilities and specialized treatment centers, along with rising awareness regarding patient-centric care models, is further accelerating the adoption of infusion pumps. Germany’s strong medical device manufacturing base and commitment to digital health integration also contribute to its rapid market growth trajectory.

Europe Infusion Pumps Market Share

The Infusion Pumps industry is primarily led by well-established companies, including:

• BD (U.S.)
• Baxter International Inc. (U.S.)
• B. Braun Melsungen AG (Germany)
• Fresenius Kabi (Germany)
• Medtronic plc (Ireland)
• ICU Medical, Inc. (U.S.)
• Terumo Corporation (Japan)
• Smiths Medical (U.K.)
• Moog Inc. (U.S.)
• Nipro Corporation (Japan)
• Mindray Medical International Limited (China)
• Insulet Corporation (U.S.)
• Avanos Medical, Inc. (U.S.)
• Roche Diagnostics (Switzerland)
• Ypsomed Holding AG (Switzerland)
• Microport Scientific Corporation (China)
• Cardinal Health (U.S.)
• Zyno Medical (U.S.)
• SAM Medical (U.S.)
• Flowonix Medical Inc. (U.S.)

Latest Developments in Europe Infusion Pumps Market

• In April 2023, Becton Dickinson (BD) received **U.S. FDA 501(k) clearance for its updated BD Alaris Infusion System, a modular platform that combines large-volume pumps, syringe pumps, and patient-controlled analgesia capabilities with new hardware, updated software, and enhanced cybersecurity features. This approval came after earlier recalls of the Alaris system and was seen as a major step in addressing safety concerns while modernizing one of the industry’s most widely used infusion platform
• In April 2024, **Baxter International Inc. announced that it received U.S. FDA 510(k) clearance for its Novum IQ Large Volume Infusion Pump (LVP) integrated with Dose IQ Safety Software, expanding the company’s Novum IQ Infusion Platform with connected smart infusion technology. The platform enables clinicians to manage both large-volume and syringe infusions through a common interface and supports advanced connectivity with electronic medical records (EMR) and digital drug libraries, improving workflow and reducing errors
• In February 2024, the Plum 360™ smart infusion pump from ICU Medical was recognized as “Best in KLAS” for smart pumps, highlighting its excellence in integration with EMR systems, safety features, and reliability in diverse clinical environments — reinforcing ICU Medical’s leadership in connected infusion solutions
• In April 2025, **ICU Medical announced U.S. FDA 510(k) clearances for its Plum Solo™ precision IV pump and updated Plum Duo™ precision IV pump, along with the enhanced LifeShield™ infusion safety software, completing the initial launch of its IV Performance Platform. These precision pumps deliver highly accurate infusion performance in clinical settings while eliminating delivery variability caused by external factors, and they further expand ICU Medical’s infusion therapy portfolio
• In March 2024, **KORU Medical Systems received regulatory clearance in Japan for its FreedomEdge Infusion System, enabling broader market access in one of the world’s largest healthcare regions. The FreedomEdge system is designed primarily for subcutaneous drug delivery and chronic disease management, reflecting the growing emphasis on ambulatory and home-based infusion therapy
• In March 2024, the FDA published a voluntary removal announcement for the InfuTronix Nimbus Ambulatory Infusion Pump System due to numerous customer complaints, highlighting the importance of post-market surveillance and quality oversight in infusion devices
• In May 2025, Iradimed Corporation received U.S. FDA 510(k) clearance for its MRidium 3870 IV Infusion Pump System, marking a major advancement in MRI-compatible infusion technology. This next-generation system — designed with non-magnetic components, an ultrasonic pump motor, and an intuitive touchscreen — reinforces Iradimed’s unique position as the sole supplier of non-magnetic infusion pumps for MRI environments, improving safety and efficiency during fluid delivery in MRI procedures

SKU-1917